Official 2024 U.S. DOL Form 5500 summary for Zymeworks Biopharmaceuticals INC. (Zymeworks Biopharmaceuticals 401(k) Plan · EIN 47-2569713 · PN 001): $12.21M net assets, 76 active participants, and $72.98 per $10,000 (72.98 bps).
| Plan Sponsor | Zymeworks Biopharmaceuticals INC. |
|---|---|
| Filing Identifier | Zymeworks Biopharmaceuticals 401(k) Plan · EIN 47-2569713 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (US) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $12.21M |
| Active Participants | 76 |
| Direct Admin Fee Rate | $72.98 per $10,000 (72.98 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Empower Retirement |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI